Advances in computer hardware and computer methods are aimed at speeding up and improving all aspects of the typical drug discovery cycle (design-manufacture-test-analysis (DMTA)). Protheragen-ING has applied data-driven synthetic prediction tools to accelerate the synthesis of new molecular entities and reduce the rate of failures. https://wavefunction.protheragen-ing.com/services/computer-aided-chemical-drug-synthesis.html

Small molecules play a crucial role in modern drug discovery and development. They are typically organic compounds with a low molecular weight that can easily penetrate cell membranes, making them ideal candidates for targeting intracellular pathways and interacting with specific proteins or enzymes. Small molecule drugs have a proven track record of success in treating a wide range of diseases, including cancer, cardiovascular disorders, and infectious diseases. https://labs.protheragen-ing.com/small-molecule-development.html

Anti-bacterial APIs are a class of compounds that target bacteria and inhibit their growth or kill bacteria. They help eliminate harmful bacterial pathogens in the body and are widely used in respiratory tract infections, urinary tract infections, skin and soft tissue infections, etc. Protheragen-ING provides a full range of antimicrobial APIs to support global customer research, including but not limited to penicillins, cephalosporins, tetracyclines, macrolides, and fluoroquinolones. https://www.protheragen-ing.com/antibacterial-apis.html